[144] Essent Group LTD SEC Filing

Rhea-AI Filing Summary

Essent Group's Form 144 notifies a proposed sale of 6,451 common shares on the NYSE through UBS Financial Services, with an aggregate market value of $404,598.47. The notice lists the approximate date of sale as 08/13/2025 and reports total shares outstanding of 98,533,757.

The securities to be sold were received as restricted stock units (RSUs) from the issuer on 05/03/2024 (3,053 shares), 05/03/2023 (3,037 shares) and 05/05/2022 (361 shares). The filing indicates there were no sales by the reporting person in the past three months. The notice does not identify the named seller in the filing text.

Insights

Securities Analyst

TL;DR: Small planned RSU sale equal to a negligible fraction of outstanding shares, likely routine liquidity from compensation.

The Form 144 reports a proposed sale of 6,451 shares valued at $404,598.47 through UBS on the NYSE. Relative to the reported 98,533,757 shares outstanding, this represents roughly 0.0065% of the equity, suggesting the transaction is immaterial to the company’s capital structure. The shares were acquired as RSUs across 2022–2024, indicating the sale appears to be monetization of vested compensation rather than a sign of broader insider disposition.

Corporate Governance Expert

TL;DR: Routine disclosure consistent with Rule 144; limited governance or market impact indicated by the filing.

The notice follows Rule 144 reporting for a proposed broker-assisted sale, naming the broker and providing acquisition dates for the RSUs. The filing states "Nothing to Report" for sales in the prior three months and does not disclose any nonpublic adverse information. From a governance perspective, the document demonstrates compliance with reporting obligations but does not provide additional context about the seller's role or any trading plan.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	6451	404598.47	98533757	08/13/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	05/03/2024	RSU	Issuer			3053	05/03/2024	N/a
Common Shares	05/03/2023	RSU	Issuer			3037	05/03/2023	n/a
Common Shares	05/05/2022	RSU	Issuer			361	05/05/2022	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Essent Group (ESNT) disclose?

The filing discloses a proposed sale of 6,451 common shares via UBS Financial Services on the NYSE, with aggregate market value $404,598.47 and an approximate sale date of 08/13/2025.

How many shares were acquired and when were they issued?

The securities were received as RSUs from the issuer on 05/03/2024 (3,053 shares), 05/03/2023 (3,037 shares) and 05/05/2022 (361 shares), totaling 6,451 shares.

Did the filer report any sales in the past three months for ESNT?

The Form 144 states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

What portion of outstanding shares does the proposed sale represent for ESNT?

The filing reports 98,533,757 shares outstanding; the proposed sale of 6,451 shares equals about 0.0065% of outstanding shares.

Does the filing identify the individual seller or any trading plan?

The document does not name the person for whose account the securities are to be sold in the visible content, and no trading-plan adoption date or 10b5-1 plan details are provided.